The Relationship Between Obesity and Atherosclerotic Progression and Prognosis Among Patients With Coronary Artery Bypass Grafts. The Effect of Aggressive Statin Therapy

Journal of the American College of Cardiology

Volumn 52, Issue 8, 2008, Pages 620-625

  Wee, Christina C ^a   Girotra, Saket ^b   Weinstein, Amy R ^a   Mittleman, Murray A ^a,c   Mukamal, Kenneth J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

atherosclerosis; cardiac surgery; lipid lowering; obesity

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PLACEBO; WARFARIN;

ADULT; AGED; ANGIOPLASTY; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SMOKING;

ANTICOAGULANTS; BODY MASS INDEX; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; OBESITY; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; WARFARIN;

EID: 48849087044     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.05.021     Document Type: Article

References (30)

1. Wilson P.W., D'Agostino R.B., Sullivan L., Parise H., and Kannel W.B. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 162 (2002) 1867-1872
2. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 (2006) 1549-1555
3. Gregg E.W., Cheng Y.J., Cadwell B.L., et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 293 (2005) 1868-1874
4. McTigue K., Larson J.C., Valoski A., et al. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 296 (2006) 79-86
5. Yarnell J.W., Patterson C.C., Thomas H.F., and Sweetnam P.M. Comparison of weight in middle age, weight at 18 years, and weight change between, in predicting subsequent 14 year mortality and coronary events: Caerphilly Prospective Study. J Epidemiol Community Health 54 (2000) 344-348
6. Folsom A.R., Stevens J., Schreiner P.J., McGovern P.G., and Atherosclerosis Risk in Communities Study Investigators. Body mass index, waist/hip ratio, and coronary heart disease incidence in African Americans and whites. Am J Epidemiol 148 (1998) 1187-1194
7. Kim J., Hammar N., Jakobsson K., Luepker R.V., McGovern P.G., and Ivert T. Obesity and the risk of early and late mortality after coronary artery bypass graft surgery. Am Heart J 146 (2003) 555-560
8. Jin R., Grunkemeier G.L., Furnary A.P., and Handy Jr. J.R. Is obesity a risk factor for mortality in coronary artery bypass surgery?. Circulation 111 (2005) 3359-3365
9. Van Gaal L.F., Mertens I.L., and De Block C.E. Mechanisms linking obesity with cardiovascular disease. Nature 444 (2006) 875-880
10. Greenberg A.S., and Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83 (2006) 461S-465S
11. Birkmeyer N.J., Charlesworth D.C., Hernandez F., et al., Northern New England Cardiovascular Disease Study Group. Obesity and risk of adverse outcomes associated with coronary artery bypass surgery. Circulation 97 (1998) 1689-1694
12. Yap C.H., Mohajeri M., and Yii M. Obesity and early complications after cardiac surgery. Med J Aust 186 (2007) 350-354
13. Gruberg L., Mercado N., Milo S., et al., Arterial Revascularization Therapies Study Investigators. Impact of body mass index on the outcome of patients with multivessel disease randomized to either coronary artery bypass grafting or stenting in the ARTS trial: the obesity paradox II?. Am J Cardiol 95 (2005) 439-444
14. Hamman B.L., Filardo G., Hamilton C., and Grayburn P.A. Effect of body mass index on risk of long-term mortality following coronary artery bypass grafting. Am J Cardiol 98 (2006) 734-738
15. Gurm H.S., Whitlow P.L., Kip K.E., and BARI Investigators. The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol 39 (2002) 834-840
16. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med 336 (1997) 152-162
17. Ridker P.M., Cannon C.P., Morrow D., et al., Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352 (2005) 20-28
18. Campeau L., Hunninghake D.B., Knatterud G.L., et al., Post CABG Trial Investigators. Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Circulation 99 (1999) 3241-3247
19. Knatterud G.L., Rosenberg Y., Campeau L., et al., Post CABG Investigators. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Circulation 102 (2000) 157-165
20. World Health Organization. Obesity: preventing and managing the global epidemic. WHO Technical Report Series no. 894 (2000), World Health Organization, Geneva
21. Domanski M.J., Borkowf C.B., Campeau L., et al., Post CABG Investigators. Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. J Am Coll Cardiol 36 (2000) 1877-1883
22. The coronary primary prevention trial: design and implementation: the Lipid Research Clinics Program. J Chronic Dis 32 (1979) 609-631
23. Curtis J.P., Selter J.G., Wang Y., et al. The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165 (2005) 55-61
24. Hall J.A., French T.K., Rasmusson K.D., et al. The paradox of obesity in patients with heart failure. J Am Acad Nurse Pract 17 (2005) 542-546
25. Nigam A., Wright R.S., Allison T.G., et al. Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death. Int J Cardiol 110 (2006) 153-159
26. Kalantar-Zadeh K., Abbott K.C., Salahudeen A.K., Kilpatrick R.D., and Horwich T.B. Survival advantages of obesity in dialysis patients. Am J Clin Nutr 81 (2005) 543-554
27. Lavie C.J., Osman A.F., Milani R.V., and Mehra M.R. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 91 (2003) 891-894
28. Wilson D.O., Rogers R.M., Wright E.C., Anthonisen N.R., and The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Body weight in chronic obstructive pulmonary disease. Am Rev Respir Dis 139 (1989) 1435-1438
29. Rana J.S., Mukamal K.J., Morgan J.P., Muller J.E., and Mittleman M.A. Obesity and the risk of death after acute myocardial infarction. Am Heart J 147 (2004) 841-846
30. Knatterud G.L., White C., Geller N.L., et al. Angiographic changes in saphenous vein grafts are predictors of clinical outcomes. Am Heart J 145 (2003) 262-269